Coordination of DNA repair and transcription by ubiquitin modification at DNA double strand breaks
DNA 双链断裂处泛素修饰协调 DNA 修复和转录
基本信息
- 批准号:10380138
- 负责人:
- 金额:$ 36.32万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-04-01 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:BRCA1 geneCellsCharacteristicsChromatinComplexDNADNA DamageDNA Double Strand BreakDNA RepairDNA Repair GeneDNA Repair InhibitionDefectDetectionDiseaseEventFailureGenetic TranscriptionGenomeGenome StabilityGoalsHealthHistone H2AHumanIndividualIonizing radiationLeadLesionLinkLysineMediatingMethionineModelingModificationMonoubiquitinationMutationN-terminalPathway interactionsPlayPolyubiquitinPolyubiquitinationPost-Translational Protein ProcessingProductionProteinsReaderRegulationRoleSignal TransductionSiteSystemTranscriptTranslationsUbiquitinUbiquitinationataxia telangiectasia mutated proteincytotoxicdesigngene repressiongenome integrityimprovedinsightnovelp53-binding protein 1preventrecruitrepairedresponserestriction enzymetool
项目摘要
ABSTRACT
DNA double-strand breaks (DSBs) are one of the most deleterious lesions. The cellular responses to DSBs
involve a sophisticated DNA damage response network that detects, signals and repairs the lesion; failure of
this system results in mutation, deletion and other alteration of genome and underlies many diseases. Post-
translational modifications by covalent attachment of ubiquitin to proteins, known as ubiquitination, play
important regulatory roles in the DNA damage response. Previous studies, including ours, have illustrated that,
upon DSBs detection and activation of the DNA damage response kinase ATM, Lys63-linked ubiquitination of
histone H2A/H2AX on damaged chromatin is critical in recruiting DNA damage repair proteins, including
53BP1 and BRCA1, to the damage sites. However, much remains unknown about the complexity of ubiquitin
modifications and their roles in the DNA damage response. We have discovered that Lys11-linkage–specific
ubiquitin modification occurs on damaged chromatin that regulates repression of transcription at DSBs,
revealing Lys11-linkage ubiquitin modification as a new signaling and regulatory platform in the response to
DSBs. We further showed that this modification is ATM dependent and catalyzed by RNF8 and Ube2S. In
addition, cells deficient in Lys11-linkage ubiquitin modification displayed increased sensitivity to ionizing
radiation. It indicates a model that DNA repair and transcription can be regulated by distinct linkage-specific
ubiquitin modifications at DSBs. However, it is not clear whether these two seemingly parallel linkage-specific
ubiquitination pathways are coordinated to regulate DNA repair and transcription in the cellular responses to
DSBs. The objective of this proposal is to identify the crosstalk between Lys63- and Lys11-linkage modification
on damaged chromatin and determine the underlying mechanisms through which it coordinates transcriptional
repression and DNA repair. We will pursue the following specific aims: 1) determine the crosstalk between
Lys11- and Lys63-linkage ubiquitination mediated by Cezanne to regulate DNA repair; 2) determine additional
mechanisms underlying the coordination of DNA repair and transcriptional inhibition; 3) determine the role of
Lys11- and Lys63-linkage ubiquitination at defined DSB sites in regulating DNA repair and inhibition of
transcription. Our findings should provide novel insights into the understanding of how ubiquitin modification at
DSBs is involved in signaling events to regulate inhibition of transcription and repair. Our long-term goal is to
decipher the complex DNA response network that protects genome integrity, which is essential for design of
tools and treatment to improve human health.
抽象的
DNA双链断裂(DSB)是最删除的病变之一。对DSB的细胞反应
涉及一个复杂的DNA损伤响应网络,该网络检测,信号和修复病变;失败
该系统导致基因组的突变,缺失和其他改变,并构成许多疾病。邮政-
通过将泛素的共价附着(称为泛素化)的共价附着来进行翻译修饰
DNA损伤反应中的重要调节作用。以前的研究,包括我们的研究,都说明了,
DSB检测和激活DNA损伤反应激酶ATM,LYS63连接的泛素化
损坏的染色质上的Hisstone H2A/H2AX对于招募DNA损伤修复蛋白至关重要,包括
53BP1和BRCA1到损坏位点。但是,对泛素的复杂性仍然未知
修饰及其在DNA损伤反应中的作用。我们发现lys11-link-tempific
泛素修饰发生在受损的染色质上,该染色质调节DSBS的转录表达,
揭示Lys11连接泛素修饰是一种新的信号传导和调节平台
DSB。我们进一步表明,这种修饰取决于ATM,并由RNF8和UBE2S催化。在
此外,缺乏Lys11-链接泛素修饰的细胞显示出对电离的敏感性提高
辐射。它表明一个模型,即DNA修复和转录可以通过不同的连锁特定的调节
DSBS的泛素修饰。但是,目前尚不清楚这两个看似平行的链接是否特定于
泛素化途径是协调的,以调节细胞对的DNA修复和转录
DSB。该建议的目的是确定Lys63-和Lys11-Linkage修改之间的串扰
关于损坏的染色质并确定其协调转录的基本机制
抑制和DNA修复。我们将追求以下特定目标:1)确定
塞尚(Cezanne)介导的DNA修复介导的Lys11-和Lys63-LINK泛素化; 2)确定其他
DNA修复和转录抑制协调的基础机制; 3)确定
在调节性DNA修复中定义的DSB位点的Lys11-和Lys63-LINK泛素化和抑制
转录。我们的发现应该为理解泛素修饰的理解提供新颖的见解
DSB参与信号事件以调节转录和修复的抑制。我们的长期目标是
破译保护基因组完整性的复杂DNA响应网络,这对于设计至关重要
工具和治疗以改善人类健康。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Bin Wang其他文献
Photodegradation of Dechlorane Plus in n-nonane under the irradiation of xenon lamp
氙灯照射下正壬烷中 DeChlorane Plus 的光降解
- DOI:
- 发表时间:
2013 - 期刊:
- 影响因子:0
- 作者:
Yang Yang;Gang Yu;Shubo Deng;Bin Wang - 通讯作者:
Bin Wang
Bin Wang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Bin Wang', 18)}}的其他基金
Targeting the PTH1R Signaling Pathway for Osteoarthritis Therapy by a Novel Disruptor Peptide
通过新型干扰肽靶向 PTH1R 信号通路治疗骨关节炎
- 批准号:
10472490 - 财政年份:2020
- 资助金额:
$ 36.32万 - 项目类别:
Targeting the ubiquitin-proteasome pathway to reverse catabolic action of PTH in bone
靶向泛素-蛋白酶体途径逆转 PTH 在骨中的分解代谢作用
- 批准号:
10656316 - 财政年份:2020
- 资助金额:
$ 36.32万 - 项目类别:
Targeting the PTH1R Signaling Pathway for Osteoarthritis Therapy by a Novel Disruptor Peptide
通过新型干扰肽靶向 PTH1R 信号通路治疗骨关节炎
- 批准号:
10667511 - 财政年份:2020
- 资助金额:
$ 36.32万 - 项目类别:
Targeting the ubiquitin-proteasome pathway to reverse catabolic action of PTH in bone
靶向泛素-蛋白酶体途径逆转 PTH 在骨中的分解代谢作用
- 批准号:
10266824 - 财政年份:2020
- 资助金额:
$ 36.32万 - 项目类别:
Targeting the PTH1R Signaling Pathway for Osteoarthritis Therapy by a Novel Disruptor Peptide
通过新型干扰肽靶向 PTH1R 信号通路治疗骨关节炎
- 批准号:
10222574 - 财政年份:2020
- 资助金额:
$ 36.32万 - 项目类别:
Biasing OGR1 signaling to optimizing PTH therapeutic effect
偏向 OGR1 信号传导以优化 PTH 治疗效果
- 批准号:
9896526 - 财政年份:2020
- 资助金额:
$ 36.32万 - 项目类别:
Targeting the PTH1R Signaling Pathway for Osteoarthritis Therapy by a Novel Disruptor Peptide
通过新型干扰肽靶向 PTH1R 信号通路治疗骨关节炎
- 批准号:
10034154 - 财政年份:2020
- 资助金额:
$ 36.32万 - 项目类别:
Coordination of DNA repair and transcription by ubiquitin modification at DNA double strand breaks
DNA 双链断裂处泛素修饰协调 DNA 修复和转录
- 批准号:
10599965 - 财政年份:2020
- 资助金额:
$ 36.32万 - 项目类别:
Targeting the ubiquitin-proteasome pathway to reverse catabolic action of PTH in bone
靶向泛素-蛋白酶体途径逆转 PTH 在骨中的分解代谢作用
- 批准号:
10450164 - 财政年份:2020
- 资助金额:
$ 36.32万 - 项目类别:
Biasing OGR1 signaling to optimizing PTH therapeutic effect
偏向 OGR1 信号传导以优化 PTH 治疗效果
- 批准号:
10092958 - 财政年份:2020
- 资助金额:
$ 36.32万 - 项目类别:
相似国自然基金
钛合金表面微区电势差特征促细胞功能表达及其免疫微环境作用机制
- 批准号:32371390
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
结外鼻型NK/T细胞淋巴瘤免疫特征分析与临床转化研究
- 批准号:82370199
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
肿瘤相关性上皮细胞亚群的特征鉴定及其在宫颈癌发病中的机制研究
- 批准号:82372637
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
系统性红斑狼疮粒-单核-树突细胞系中PLSCR1介导的I型干扰素诱导表达特征及调控机制研究
- 批准号:82300805
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
具备植入前特征的人滋养外胚层干细胞(TESC)的建立与发育潜能研究
- 批准号:32370842
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
UBR5's mechanisms of action in tumorigenesis and immunoregulation
UBR5在肿瘤发生和免疫调节中的作用机制
- 批准号:
10659844 - 财政年份:2023
- 资助金额:
$ 36.32万 - 项目类别:
H2AJ as a regulator of placental senescence and genome organization
H2AJ 作为胎盘衰老和基因组组织的调节剂
- 批准号:
10677156 - 财政年份:2023
- 资助金额:
$ 36.32万 - 项目类别:
Exploiting markers of genomic instability in high-risk pre-invasive ovarian cancer
利用高风险浸润前卵巢癌基因组不稳定性标记
- 批准号:
10719535 - 财政年份:2023
- 资助金额:
$ 36.32万 - 项目类别:
Methionine and PI3K Metabolism Drive CIMP in EBV Epithelial Cancers
蛋氨酸和 PI3K 代谢驱动 EBV 上皮癌中的 CIMP
- 批准号:
10627692 - 财政年份:2023
- 资助金额:
$ 36.32万 - 项目类别:
Homologous recombination repair capacity in peripheral blood lymphocytes as a breast cancer risk factor
外周血淋巴细胞同源重组修复能力作为乳腺癌危险因素
- 批准号:
10475413 - 财政年份:2022
- 资助金额:
$ 36.32万 - 项目类别: